NOAEL Studies
Cosmetic Ingredient
Polysorbate 40 NOAEL Studies
INCI: POLYSORBATE 40
CAS: 9005-66-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
CIR Safety Assessment 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| CIR Safety Assessment | NOAEL | =1600 | mg/kg/d | C57BL/6J mice | Oral (gavage) | 28 days | General toxicity | {"citation":"46","dose":"1600 mg/kg/d","effect":"No adverse effects or mortalities","page":7,"pdf":"FR696.pdf","row_type":"noael_study","study_id":"NOAEL_PS40_MOUSE_GAVAGE_HIGHFAT_1"} |
| CIR Safety Assessment | NOAEL | =1600 | mg/kg/d | C57BL/6J mice | Oral (gavage) | 28 days | General toxicity | {"citation":"46","dose":"1600 mg/kg/d","effect":"No adverse effects or mortalities","page":7,"pdf":"FR696.pdf","row_type":"noael_study","study_id":"NOAEL_PS40_MOUSE_GAVAGE_HIGHFAT_1"} |
| CIR Safety Assessment | NOAEL | =1600 | mg/kg/d | C57BL/6J mice | Oral (gavage) | 28 days | General toxicity | {"citation":"46","dose":"1600 mg/kg/d","effect":"No adverse effects or mortalities","page":7,"pdf":"FR696.pdf","row_type":"noael_study","study_id":"NOAEL_PS40_MOUSE_GAVAGE_HIGHFAT_1"} |
| CIR Safety Assessment | NOAEL | =1600 | mg/kg/d | C57BL/6J mice | Oral (gavage) | 28 days | General toxicity | {"citation":"46","dose":"1600 mg/kg/d","effect":"No adverse effects or mortalities","page":7,"pdf":"FR696.pdf","row_type":"noael_study","study_id":"NOAEL_PS40_MOUSE_GAVAGE_HIGHFAT_1"} |
openFDA substances 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 4NR71FN0IA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4NR71FN0IA"} |
| openFDA substances | FDA UNII substance identifier | 4NR71FN0IA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4NR71FN0IA"} |
| openFDA substances | FDA UNII substance identifier | 4NR71FN0IA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4NR71FN0IA"} |
| openFDA substances | FDA UNII substance identifier | 4NR71FN0IA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4NR71FN0IA"} |
| openFDA substances | FDA UNII substance identifier | STI11B5A2X | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"STI11B5A2X"} |
| openFDA substances | FDA UNII substance identifier | STI11B5A2X | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"STI11B5A2X"} |
| openFDA substances | FDA UNII substance identifier | STI11B5A2X | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"STI11B5A2X"} |
| openFDA substances | FDA UNII substance identifier | STI11B5A2X | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"STI11B5A2X"} |